Search Results - "Bidar, Frank"

Correction to: Recombinant human interleukin-7 reverses T cell exhaustion ex vivo in critically ill COVID-19 patients.

Authors: Bidar, Frank Hamada, Sarah Gossez, Morgane et al.

Source: Annals of Intensive Care. 4/1/2022, Vol. 12 Issue 1, p1-3. 3p.

Anticoagulation Strategies for Continuous Renal Replacement Therapy in France: A Survey of Practices.

Authors: Pible, Justine Bidar, Frank Chardon, Nicolas et al.

Source: Blood Purification. Jan2025, Vol. 54 Issue 1, p1-8. 8p.

Recombinant human interleukin-7 reverses T cell exhaustion ex vivo in critically ill COVID-19 patients.

Authors: Bidar, Frank Hamada, Sarah Gossez, Morgane et al.

Source: Annals of Intensive Care. 4/1/2022, Vol. 12 Issue 1, p1-12. 12p.

Recombinant human interleukin-7 reverses T cell exhaustion ex vivo in critically ill COVID-19 patients.

Authors: Bidar, Frank Hamada, Sarah Gossez, Morgane et al.

Source: Annals of Intensive Care. 3/5/2022, Vol. 12 Issue 1, p1-12. 12p.

Recombinant human interleukin-7 reverses T cell exhaustion ex vivo in critically ill COVID-19 patients.

Authors: Bidar, Frank Hamada, Sarah Gossez, Morgane et al.

Source: Annals of Intensive Care. 3/4/2022, Vol. 12 Issue 1, p1-12. 12p.

The Immunomodulatory Potential of Hemoadsorption in Burn Care.

Authors: Chardon, Nicolas Bidar, Frank Abraham, Paul Samuel et al.

Source: Blood Purification. Jun2025, p1-9. 9p. 1 Illustration.

Association of pronounced elevation of NET formation and nucleosome biomarkers with mortality in patients with septic shock.

Authors: Haem Rahimi, Muzhda Bidar, Frank Lukaszewicz, Anne-Claire et al.

Source: Annals of Intensive Care. 10/17/2023, Vol. 13 Issue 1, p1-9. 9p.

Interpreting circuit lifespan in the “E-CRRT” trial: considerations and limitations.

Authors: Bidar, Frank Petit, Matthieu Fellahi, Jean-Luc et al.

Source: Intensive Care Medicine. Mar2026, p1-2.

Characteristics and outcomes of ECMO cannula-related infections: a European multicenter retrospective study.

Authors: Ortuno, Sofia Massart, Nicolas Vidal, Charles et al.

Source: Annals of Intensive Care. 3/20/2025, Vol. 15 Issue 1, p1-10. 10p.

Altered Ex Vivo NLRP3 Inflammasome Activation Is Associated with 28-Day Mortality in Septic Patients.

Authors: Coudereau, Rémy Monneret, Guillaume Lukaszewicz, Anne-Claire et al.

Source: Viruses (1999-4915). Dec2023, Vol. 15 Issue 12, p2419. 14p.

Concomitant Assessment of Monocyte HLA-DR Expression and Ex Vivo TNF-α Release as Markers of Adverse Outcome after Various Injuries—Insights from the REALISM Study.

Authors: Bidar, Frank Bodinier, Maxime Venet, Fabienne et al.

Source: Journal of Clinical Medicine. Jan2022, Vol. 11 Issue 1, p96. 1p.